Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
127 participants
INTERVENTIONAL
2021-07-01
2022-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mental Stress Ischemia: Biofeedback Study
NCT02657382
Biofeedback and Hydrogen Water as Treatments for Chronic Fatigue Syndrome
NCT05397626
REVEAL for Respiration Detection
NCT01956578
Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2
NCT00180531
The HF-HRV Registry
NCT00236236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HRV Biofeedback
5 minute daily sessions of HRV biofeedback
HRV Biofeedback
5 minute daily sessions of HRV biofeedback
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HRV Biofeedback
5 minute daily sessions of HRV biofeedback
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligible participants were 18 years of age or greater.
* Had an iPhone series 5 or greater.
* Had or were willing to wear an Apple Watch 4 or greater.
* Potential participants were excluded if they had an underlying chronic disease or used a medication that is known to impact autonomic nervous system function.
Exclusion Criteria
* rheumatoid arthritis
* systemic lupus erythematosus
* inflammatory bowel disease
* Use of medications that impact heart rate variability including but not limited to:
* beta-blockers (ie. atenolol, carvedilol, metoprolol, Coreg, Tenormin, Normodyne, Trandate)
* digoxin
* calcium channel blockers (ie. Norvasc, amlodipine, Cardene, nicardipine, Procardia, nifedipine, Cardizem, diltiazem)
* regularly used benzodiazepines
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Hirten
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Hirten
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY-21-00596
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.